Joanne Montgomery, MD
Dermatology · West Fargo, NDNPI 1609040427
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,185 of the $1,408 with a category attached, or 84.2%. It is spread thinly across 15 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $406, 5.5 times the $74 reported in 2019.
Across 60 payments — averaging $23.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$289
- AbbVie$159
- Sun Pharmaceutical Industries Inc.$131
- Incyte Corporation$131
- UCB, Inc.$106
- Sanofi-aventis U.S. LLC$99
- plus $493 from 9 others
What the payments were for
- Speaking & faculty fees$242%
- Food & beverage$1,18584%
- Education$19914%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 21 | $289 |
| AbbVie(2 entities) | 6 | $159 |
| Sun Pharmaceutical Industries Inc. | 3 | $131 |
| Incyte Corporation | 4 | $131 |
| UCB, Inc. | 3 | $106 |
| Sanofi-aventis U.S. LLC | 1 | $99 |
| E.r. Squibb & Sons, L.L.C. | 3 | $94 |
| Boehringer Ingelheim | 3 | $88 |
| Sanofi | 5 | $88 |
| Galderma Laboratories, L.p. | 4 | $71 |
| Gilead | 2 | $59 |
| Johnson & Johnson | 2 | $40 |
| Amgen | 1 | $22 |
| LEO Pharma Inc. | 1 | $16 |
| Novartis | 1 | $15 |
How this compares
$1,408 in reported general payments places this provider in the 55th percentile of 29 dermatology providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 13 | $255,490 |
| Taltz AutoinjectorIxekizumab | 18 | $141,796 |
| Dupixent PenDupilumab | 37 | $136,809 |
| Dupixent SyringeDupilumab | 25 | $91,795 |
| Acitretin | 11 | $8,414 |
| Tacrolimus | 61 | $5,728 |
| Ketoconazole | 230 | $5,170 |
| Clobetasol Propionate | 105 | $4,503 |
| Metronidazole | 98 | $4,038 |
| Calcipotriene | 22 | $3,990 |
| Fluorouracil | 56 | $3,544 |
| Desoximetasone | 18 | $2,277 |
| Clindamycin Phosphate | 47 | $1,350 |
| Triamcinolone Acetonide | 146 | $1,294 |
| Hydrocortisone | 176 | $1,264 |
Paid to pharmacies, not to this prescriber.
Other dermatology in West Fargo
- Imran AslamBismarck$280K
- Michael BlankinshipFargo$130K
- Mary LogueMinot$9K
- Rachel NessFargo$8K
- Margaret NewsomeMinot$8K
- Alexandra GeigerBismarck$4K
- Nicole SotoBismarck$4K
- Megan StrandBismark$3K
- Amanda BeehlerFargo$2K
- Natalie KollmanFargo$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.